Clinical Trials List
Protocol NumberCBAF312D2301
Active
2021-12-01 - 2029-08-30
Phase III
Recruiting3
ICD-10G35
Multiple sclerosis
ICD-9340
Multiple sclerosis
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- WEN-CHIN WENG 無
- 王麗君 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
120 participants
